Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT02324803
Status:
UNKNOWN
Last Update Posted:
2014-12-24
First Post:
2014-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Sponsor:
Southern China Urology Cancer Consortium
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SUCC001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None